Wei-Han Hu | Radiation Oncology | Sun Yat-sen University Cancer Center-Sun Yat-sen University Cancer Center

Name: Wei-Han Hu

Title: Professor,Chief Physician

Email: huwh@sysucc.org.cn

Phone:

Profile

Dr. Wei-Han Hu was born in 1954, and obtained his Bachelors in Medicine (equivalent to MD in the US) at Sun Yat-sen Medical college in 1976. Dr. Hu is a professor in the Department of Radiation Oncology, at Sun Yat-sen University Cancer Center. Prof. Hu is also appointed as Chief Physician, Master Supervisor, and tutor of long-term medical education. Prof. Hu has been engaged in clinical radiotherapy, radiobiological research, and education for 40 years. He is good at radiotherapy for head and neck carcinoma, particularly doing well in a new technique radiation for nasopharyngeal carcinoma, nasal cavity and ethmoid sinus tumors, and hypopharyngeal carcinoma. The research field includes nasopharyngeal carcinoma complicating dermatomyositis, visual function damage caused by radiation, clinical TNM stage for nasal cavity cancer, HPV infection in H&N carcinoma, and radiotherapy combining with biological therapy/molecular targeted therapy for H&N carcinoma. Prof. Hu has published more than 60 academic papers, undertaken numerous research projects, and brought up more than 10 post-graduates.

Interests

Nasopharyngeal carcinoma complicating dermatomyositis, visual function damage caused by radiation, clinical TNM stage for nasal cavity cancer, HPV infection in H&N carcinoma, and radiotherapy combining with biological therapy/molecular targeted therapy for H&N carcinoma.

Education

MD from Sun Yat-sen Medical college in 1976

Publications

1.胡伟汉,洪明晃,陈勇，闵华庆.鼻咽癌合并皮肌炎远期疗效分析.中华放射肿瘤学杂志,1993,2(1):12.

2.胡伟汉,陈德林,闵华庆.鼻咽癌合并皮肌炎45例的临床研究.中华放射肿瘤学杂志,1995,4(3):169～170.

3.胡伟汉,黄时洲,吴德正,等.鼻咽癌放射治疗对视路功能损伤的研究.中华放射肿瘤学杂志,1995,4(3):150～153.

4.Wei-hanHu,De-ling Chen,Hua-Qing Ming.Study of 45 Cases of Nasopharygeal Carcinoma with Dermatomyotitis. American Journal of Clinical Oncology, 1996,19(1):35～38.

5.胡伟汉主编导.常用放疗设备及其临床应用(教学录像片). CMB ( 美国中华医学基金会 )资助，1992,2.中华医学音像出版社发行.

6.胡伟汉主编导.热疗原理与治癌(教学录像片) CMB ( 美国中华医学基金会 )资助，1994,11.中华医学音像出版社发行.

7.胡伟汉,龙时先,周兰荪,等.鼻咽癌放射治疗对视诱发电位的早期影响.癌症,1997,16:(增刊)93～94.

8.胡伟汉,王晓明,梁碧玲.原发性肝胆管癌蝶窦转移1例.癌症（增刊）1999,18:58

9.胡伟汉,陈明,骆福添,等.IE期鼻腔非霍奇金氏淋巴瘤的治疗与预后.海南医学杂志,1999,12(6):93～94.

10.胡伟汉,余敏忠,龙时先,等.鼻咽癌放疗的视诱发电位研究.中国肿瘤临床与康复,2001,8:60-62 增刊.

11.胡伟汉,陈明,骆福添,等.IE期鼻腔非霍奇金氏淋巴瘤预后的多因素分析.中华肿瘤杂志,2001,23(3):240-243.

12.Wei-han Hu, Ming Chen, Ying Sun, et al. Multivariate Prognostic Analysis of Stage IE PrimaryNon-Hodgkin’s Lymphomas of the Nasal Cavity. American Journal of Clinical Oncology,2001,24(3):286-289.

13.胡伟汉,余敏忠,龙时先,等.放射线治疗鼻咽癌对视诱发电位改变的研究. 中华肿瘤杂志,2002,24(2)147-150.

14.胡伟汉, 陈立新.鼻咽癌放射治疗技术新进展.广东医学,2002.23(4)333-334.

15.胡伟汉,谢方云,陈德珠,等.60例上皮源性鼻腔癌的临床疗效分析.中华肿瘤杂志,2002.24(6)592-594

16.胡伟汉,谢方云,赖越元,等.鼻腔腺样囊性癌的临床研究.中华放射肿瘤学杂志,2003.12(3)73-76.

17.胡伟汉,谢方云,傅晓莹,等.23例原发性筛窦恶性肿瘤临床分析.中华放射肿瘤学杂志,2003.23(3)207-208.

18.徐伯平,黄时洲,胡伟汉(通讯作者),等.中药防治鼻咽癌放疗致视后路损伤的研究,中国中西医结合杂志,2003,23(9):661-663.

19.Hu Wei-han, Yu Min-zhong, Long Shi-xian, at al. Impairment of Optic Path due to Radiotherapy for Nasopharyngeal Cacinoma. DocumentaOphthalmologica, 2003. DocumentaOphthalmologica 107: 101–110.

20.胡伟汉,谢方云,伍勇,等. 原发性鼻腔黑色素瘤24例临床分析.中华放射肿瘤学杂志,2004.13(1)8-11.

21.聂大红,胡伟汉(通讯作者),高远红,等.鼻腔非霍奇金淋巴瘤的化学治疗及放射治疗.中华肿瘤杂志,2004.26(5)312-314.

22.胡伟汉,谢方云,方盛华,等.87例鼻腔鳞癌的治疗与预后.中华放射肿瘤学杂志,2004.13(3):159-62.

23.胡伟汉,谢方云,陈德珠,等.98例鼻腔癌的治疗与预后. 癌症, 2004. 11s(23): 1542-1545.

24.胡伟汉,谢方云,方盛华,等.163例鼻腔恶性肿瘤治疗分析.中华肿瘤杂志,2005.27(2):65-69.

25.潘燚,胡伟汉(通讯作者),高艺,等.鼻咽癌放疗后视野与诱发电位的改变.癌症,2005.24(6): 722-726.

26.胡伟汉,张国义,刘立志,等.PET-CT与MRI诊断鼻咽癌淋巴结转移的对比研究,癌症,2005.24(7): 855-860.

27.胡伟汉,赵雁梨,方盛华,等.鼻腔癌临床TNM新分期的研究.中华肿瘤杂志,2005.27(6):355-359.

28.张国义,胡伟汉(通讯作者).124例上颌窦癌预后因素分析.中华放射肿瘤学杂志,2005.14(5): 378-382.

29.伍勇,胡伟汉(通讯作者),夏云飞,等. 192例鼻咽癌放疗后无瘤生存患者的生存质量分析.癌症,2005.24(11): 1376-1383.

30.张玉晶,胡伟汉(通讯作者),刘慧,等.鼻型NK/T细胞淋巴瘤的临床和预后分析, 中华肿瘤杂志,2006,28(1):50-53.

31.潘燚,胡伟汉(通讯作者),谢丹,等. 脑胶质瘤组织中Survivin细胞核表达与预后的关系,癌症,2006,25(5):635-639.

32.张国义,刘立志,胡伟汉(通讯作者),等.鼻咽癌咽后淋巴结转移磁共振诊断标准的研究,中华医学杂志,2006,86(18):1265-1267.

33.张国义,胡伟汉(通讯作者),刘立志,等. PET／CT与MRI在鼻咽癌淋巴结转移诊断和N分期中的比较研究.中华肿瘤杂志,2006,28(5):381-384.

34.秦海燕,胡伟汉(通讯作者),李小芳,等. 原发性扁桃体NHL临床特点和预后分析,现代肿瘤医学,2007,15 (1): 15-18.

35.梁颖,高剑铭,胡伟汉(通讯作者),等.诱导化疗联合同期放化疗对局部晚期鼻咽癌的远期疗效,癌症,2007,26(8):885-889.

36.秦海燕,胡伟汉(通讯作者),张晓实,等.细胞因子诱导杀伤细胞联合白介素-2治疗头颈部肿瘤近期疗效观察,广东医学, 2007,28(4):560-562.

37.秦海燕,胡伟汉(通讯作者),张晓实,等.CIK细胞联合白介素- 2对鼻咽癌病人免疫功能及EB病毒指标的影响. 现代肿瘤医学,2007(12):1747-9.

38.Wu Yong, Hu wei-han(通讯作者), Xia yun-fei, et al. Quality of life of nasopharyngeal carcinoma survivors in Mainland China, Quality of Life Research,2007,16:65-74.

39.潘燚,胡伟汉(通讯作者),谢丹,等.生存素在细胞核及细胞质中的表达与脑胶质瘤患者预后的关系.中华医学杂志,2007,87(5):325-329.（暂不提供全文下载）

40.徐韬,胡伟汉（通讯作者）,高远红,等. 3-（5'羟甲基-2'呋喃基）-1苯甲基吲唑联合放疗治疗Lewis移植瘤小鼠的实验研究.肿瘤研究与临床,2008,20(2): 76-79,86.

41.徐韬,胡伟汉（通讯作者）.低氧诱导因子与肿瘤放射治疗. 国际肿瘤学杂志, 2008, 35(3): 173-176.

42.徐韬,胡伟汉（通讯作者）.抑制新生血管联合放射治疗的机制探讨及存在问题. 实用肿瘤学杂志,2008,22(2):155-159.

43.徐韬,胡伟汉（通讯作者）,伍国号,等.151例下咽鳞癌的治疗方式与预后.中国肿瘤临床,2008,35(11): 606-610.

44.王芳,徐韬,胡伟汉（通讯作者）,等. 原发舌根非霍奇金淋巴瘤的临床分析. 中国肿瘤临床,2008,19(35):1106－1108 .

45.王芳,王汉渝,胡伟汉（通讯作者）,等. 调强放疗联合西妥昔单抗及顺铂治疗晚期鼻咽癌.中国肿瘤生物治疗杂志,2008,15(5):489-493.

46. 伍勇,胡伟汉（通讯作者）,毛平,等. SF-36中文版健康状况调查表评价鼻咽癌疗后长期存活者适用性研究.中华放射肿瘤学杂志,2010,19(3):201-204.

47.胡伟汉.对鼻咽癌诊治现状的若干看法.肿瘤研究与临床,2010,22(8):505-508.

48.张国义,魏伟宏,胡伟汉（通讯作者）,等.鼻咽癌咽后淋巴结转移分布规律的研究.肿瘤研究与临床,2010,22(8):509-511.

49.伍勇,刘国龙,胡伟汉（通讯作者）,等.生存质量对鼻咽癌长期生存预后的影响. 肿瘤研究与临床,2010,22(8):523-525.

50.葛楠,林焕新,胡伟汉（通讯作者）,等.117例鼻咽癌适形调强放射治疗的预后研究.肿瘤研究与临床,2010,22(8):530-533.

51.王顺兰,陈明远,胡伟汉（通讯作者）,等.鼻咽癌放疗后第二原发舌鳞癌35例. 肿瘤研究与临床,2010,22(8):534-536.

52. Nan Ge, …, Wei-Han Hu（通讯作者）, Tiebang Kang. Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma. Journal of Translational Medicine,2010,8:94

53. 张国义,魏伟宏,胡伟汉（通讯作者）,等.正电子发射断层显像-计算机断层显像在鼻咽癌远处转移诊断中的应用价值.肿瘤研究与临床,2011,23(5):294-298.

54. Ting Jin, Wei-Han Hu(通讯作者), Li-Bing Guo, et al. Treatment results and prognostic factors of patients undergoing postoperative radiotherapy for laryngeal squamous cell carcinoma. Chinese Journal of Cancer,2011,30(7):482-489.

55. 金厅,王芳,胡伟汉(通讯作者),等.HIF-1α与VEGF在下咽鳞癌中的表达及其临床意义.中华放射肿瘤学杂,2011,20(5):385-389.

56. Ting Jin,,Huan-XinLin,HuiLin,Li-Bing Guo, Nan Ge,Xiu-Yu Cai,RuiSun,Wen-KuanChen,Qiu-Li Li,Wei-Han Hu（通讯作者）,Expression TGM2 and BNIP3 have prognostic significance in laryngeal cancer patients receiving surgery and postoperative radiotherapy: A retrospective study.Journal of Translational Medicin,2012,10:64

57. Zeng R, Dai Q, Peng Z, Cai P, Hu W. Prediction of occult cervical lymph node metastasis in clinically negative supraglottic squamous cell carcinoma. Head Neck Oncol. 2012 Oct 27;4(3):69.

58. Jin Y, Cai XY, Shi YX, et al. Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinoma. J Cancer Res Clin Oncol 2012; 138: 1717-25.

59. Lin H, linHX, Hu Wei-Han（通讯作者）et al. Chemotherapy plus radiotherapy makes curability a possibility for NPC patients with distant metastases at diagnosis. Head Neck Oncology. 2013 Jan 04;5(1):1

60. Lin H, linHX, HuWei-Han（通讯作者）et al.Plasma uric acid and tumor volume are highly predictive of outcome in nasopharyngeal carcinoma patients receiving intensity modulated radiotherapy. Radiat Oncology. 2013 May 15;8(1):121.

61. Cai X, Hu W, Zhang B et al. Genotyping of IL-8-251 T>A yields prognostic information in patients with gastric carcinoma. Biomarkers. 2013 Aug28；18（7）：559-564

62. 王洪智, 胡伟汉. Hpv相关头颈部肿瘤分子表型及对放化疗敏感性的影响. 癌症进展. 2014; 12(1):54-58.

63. Wang H, ...Hu Wei-Han. P16INK4A as a surrogate biomarker for human papillomavirus-associated oropharyngeal carcinoma: consideration of some aspects. Cancer Sci 2013; 104: 1553-59

64. Wei WH, Huang ZL, Li SE, Chen HM, Lin L, Zhang GY, Lu QX Wu YF, *Hu WH, *Xu T. Pretreatment Epstein-Barr Virus DNA Load and Cumulative Cisplatin Dose Intensity Affect Long-Term Outcome of Nasopharyngeal Carcinoma Treated with Concurrent Chemotherapy: Experience of an Institute in an Endemic Area. Oncology Research and Treatment.

Last Updated on: August 2014.by International Office, Sun Yat-sen University Cancer Center

Our Experts